Table 5 Dose intensity according to decrease in renal function
From: Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
|  | Group D (n = 13) | Group ND (n = 27) | p-value | ||
|---|---|---|---|---|---|
Initial dose (mg) | 24 | ||||
Time (months) | n | DI (mg/day) | n | DI (mg/day) | Â |
12 | 13 | 11.9 (7.6–13.7) | 27 | 11.6 (4–18.1) | 0.7507 |
24 | 13 | 9.7 (6–14) | 24 | 9.8 (6.7–16.4) | 0.4640 |
36 | 10 | 9.2 (5.2–13) | 14 | 9 (7.2–13.2) | 0.8836 |
48 | 6 | 8 (4.5–10.5) | 7 | 8.7 (6.3–10.1) | 0.7751 |
60 | 4 | 7.4 (4.1–10.5) | 6 | 9.05 (5.6–9.8) | 0.6698 |